Community/Retail

Although statistics gathered in 2016 indicate that we've made significant progress in reaching patients with HIV, only approximately 60% of them are in active treatment.

Amanda Bourque, a Rite Aid pharmacy technician from Coventry, Rhode Island and JoAnn Lankford, a loyal Rite Aid customer from Providence Forge, Virginia, have been selected as the winners of this year's Vote for Your Favorite Pharmacy Team Member Contest.

CVS Health has announced that Advanced Care Scripts has earned accreditation in Specialty Pharmacy from URAC, the independent leader in promoting healthcare quality through accreditation, certification and measurement.

The FDA approved 2 supplemental new drug applications (sNDAs) for Upsher-Smith Laboratories’ Qudexy XR (topiramate) extended-release capsules.

Two pharmacy owners were convicted of operating a pill mill out of their business, Medicine Center Pharmacy, in Atlanta, Georgia.

Morphine and Ticagrelor Drug Interaction

The FDA has approved Teva’s Austedo (deutetrabenazine) tablets, previously referred to as SD-809, for chorea associated with Huntington’s disease (HD).

A recent retrospective analysis showed that nearly 75% of long-term care patients with diabetes received SSI.

Rates continue to decline.

The FDA issued an alert warning consumers of a nationwide voluntary recall of Mylan’s EpiPen and EpiPen JR (epinephrine injection) Auto-Injector products due to a potentially defective part that may result in device failure.

The CVS Health Foundation have announced more than $1 million in grants to 33 Free and Charitable Clinics as part of a multi-year grant program with the National Association of Free & Charitable Clinics.

Walgreens and pharmacy benefit manager Prime Therapeutics LLC have announced the closing of their transaction to form a combined central specialty pharmacy and mail services company, as part of a strategic alliance first announced by the companies last August.

The CVS Health Charity Classic has announced that it has added a two-day family friendly, food festival that will kick off the Charity Classic event series.

McKesson Corporation has announced that it has completed the previously announced acquisition of CoverMyMeds LLC.

An adverse effect with interferon-ribavirin Hepatitis C therapy that does not stop after discontinuation.

Pharmacists do more than just filling orders. They are the second check and sometimes the ones to find issues overlooked.

Over the years, a number of landmark clinical studies on COPD have been published, shaping how we treat the disease today.

Two of the biggest names in ladies golf will return to Grand Rapids in June to compete in the 2017 Meijer LPGA Classic for Simply Give.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

In violation of law, state plan would reimburse pharmacies below the actual cost of dispensing prescriptions to Medicaid patients

Judy Sommers Hanson, PharmD, FAPhA, chats with Pharmacy Times about the important role that pharmacists can play in educating the public on B1 and methotrexate use.

President Donald Trump promises to tackle the nation’s opioid crisis with a recently-signed executive order launching a commission to fight drug addiction.

According to the CDC head lice is the most common and least harmful infestation in the United States as healthcare providers treat about 12 million cases per year resulting in an estimated 1 billion dollars being spent on treatment costs.

The Global Patient Safety Challenge on Medication Safety aims to address the weaknesses in health systems that lead to medication errors and the severe harm that results.

Pharmacists need to remain aware of certain interactions that can occur with medications and nutraceuticals.

This week’s Walgreens Flu Index shows that a number of states, including the Carolinas, Tennessee, and Louisiana, continue to see widespread flu activity in the final week of March.

Patients can use guidance about what vitamin products to select for their use.

The multiple sclerosis (MS) community eagerly awaited the March 28 FDA approval of ocrelizumab (Ocrevus) for treating relapsing and primary progressive forms of MS. -